Literature DB >> 34220207

Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy.

Seung Hyun Kang1, Chang-Han Lee1,2,3,4.   

Abstract

Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced. © The Korean Society for Biotechnology and Bioengineering and Springer 2021.

Entities:  

Keywords:  Fc engineering; antibody engineering; bispecific antibody; therapeutic antibody

Year:  2021        PMID: 34220207      PMCID: PMC8236339          DOI: 10.1007/s12257-020-0181-8

Source DB:  PubMed          Journal:  Biotechnol Bioprocess Eng        ISSN: 1226-8372            Impact factor:   2.836


  124 in total

1.  Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Authors:  J A Coronella; P Telleman; T D Truong; F Ylera; R P Junghans
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism.

Authors:  Marie-Paule Lefranc; Gérard Lefranc
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

Review 5.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

Review 6.  Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Authors:  Louis M Weiner; Rishi Surana; Shangzi Wang
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 7.  Mouse and human FcR effector functions.

Authors:  Pierre Bruhns; Friederike Jönsson
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

Review 8.  The promise and challenge of high-throughput sequencing of the antibody repertoire.

Authors:  George Georgiou; Gregory C Ippolito; John Beausang; Christian E Busse; Hedda Wardemann; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

9.  FcγR Binding and ADCC Activity of Human IgG Allotypes.

Authors:  Steven W de Taeye; Arthur E H Bentlage; Mirjam M Mebius; Joyce I Meesters; Suzanne Lissenberg-Thunnissen; David Falck; Thomas Sénard; Nima Salehi; Manfred Wuhrer; Janine Schuurman; Aran F Labrijn; Theo Rispens; Gestur Vidarsson
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

10.  Study of the interactions of a novel monoclonal antibody, mAb059c, with the hPD-1 receptor.

Authors:  Jingxian Liu; Guiqun Wang; Liu Liu; Runjie Wu; Yi Wu; Cheng Fang; Xinhong Zhou; Jing Jiao; Ying Gu; He Zhou; Zhenhui Xie; Zhiwu Sun; Dakai Chen; Ken Dai; Dongxu Wang; Wei Tang; Teddy Tat Chi Yang
Journal:  Sci Rep       Date:  2019-11-28       Impact factor: 4.379

View more
  4 in total

Review 1.  The Contribution of Liver Sinusoidal Endothelial Cells to Clearance of Therapeutic Antibody.

Authors:  Bethany H James; Pantelitsa Papakyriacou; Matthew J Gardener; Louise Gliddon; Christopher J Weston; Patricia F Lalor
Journal:  Front Physiol       Date:  2022-01-14       Impact factor: 4.566

2.  Protective Effect of Gamma Aminobutyric Acid against Aggravation of Renal Injury Caused by High Salt Intake in Cisplatin-Induced Nephrotoxicity.

Authors:  Hyesook Lee; Seon Yeong Ji; Hyun Hwangbo; Min Yeong Kim; Da Hye Kim; Beom Su Park; Joung-Hyun Park; Bae-Jin Lee; Gi-Young Kim; You-Jin Jeon; Yung Hyun Choi
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

3.  Sequential Vaccination With Heterologous Acinetobacter baumannii Strains Induces Broadly Reactive Antibody Responses.

Authors:  Gathoni Kamuyu; Yat Suen Cheng; Sam Willcocks; Chidchamai Kewcharoenwong; Pattarachai Kiratisin; Peter W Taylor; Brendan W Wren; Ganjana Lertmemongkolchai; Richard A Stabler; Jeremy Brown
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

4.  Extending the capabilities of intact-mass analyses to monoclonal immunoglobulins of the E-isotype (IgE).

Authors:  Wenhua Yang; Daniil G Ivanov; Igor A Kaltashov
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.